Hu NZ, Hu YZ, Shi HJ, Liu GD, Qu S. Mutational characteristics in consecutive passage of rapidly replicating variants of hepatitis A virus strain H2 during cell culture adaptation. World J Gastroenterol 2002; 8(5): 872-878 [PMID: 12378633 DOI: 10.3748/wjg.v8.i5.872]
Corresponding Author of This Article
Yun-Zhang Hu, Department of Vaccine Research, Institute of Medical Biology, Chinese Academy of Medical Sciences. 379 Jiaoling Road, Kunming, 650118, Yunnan Province, China. huyunz@21cn.com
Article-Type of This Article
Viral Hepatitis
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Oct 15, 2002; 8(5): 872-878 Published online Oct 15, 2002. doi: 10.3748/wjg.v8.i5.872
Table 1 The primers used for amplification of HAV genomic RNA
Cloned fragments
Primers
Sequences
A (0.8 kb)
A1
5'-CGCCGGCGTTCAAGAGGGGTGTCCGGAG-3'
A2
5'-GAATCTCAATGCCAAATCTTGC-3'
B (0.5 kb)
B1
5'-TCTGAGGTACTCAGGGGC-3'
B2
5'-CAGTCAATGATGCTATAGAACC-3'
C (1.1 kb)
C1
5'-CCAACAGGGGGGATTGATC-3'
C2
5'-CGTTAGAAGGAGAGGTCAATC-3'
D (1.0 kb)
D1
5'-CCCTGGATTTCTGACACTCC-3'
D2
5'-CAGTGGATAACATGGCATTTG-3'
E (1.1 kb)
E1
5'-GTCTGTCACAGAACAATCAGAG-3'
E2
5'-GATCCCAGAACAGATATCTCTTAA-3'
F (1.2 kb)
F1
5'-GTTAAGAGATATCTGTTCTGGATC-3'
F2
5'-CCATCCTCCAACGAGCACTCC-3'
G (1.2 kb)
G1
5'-CAGTTCTTTAGTCATGACAGTTG-3'
G2
5'-GCCATTGGATCAATTTCAGC-3'
H (1.1 kb)
H1
5'-GAGTCCCATTTATCATCACA-3'
H2
5'-GTCCAATCAGATCAAGATTATC-3'
I (0.5 kb)
I1
5'-GATTCTCTGTTATGGAGATG-3'
I2
5'-TTTTTTTTTTTTTTTTTTTTTATTT-3'
Table 2 Titers of different passages of HAVH2K7 on KMB17 for 14 d.
Passages
Antigen titers
Infectious titers (LgCCID50/mL)
1
1:16
5.83
2
1:8
5.5
3
1:16
5.67
4
1:32
6.0
5
1:32
6.5
6
1:64
6.77
7
1:64
6.67
8
1:64
6.5
9
1:64
6.67
10
1:128
6.83
11
1:128
7.0
12
1:256
7.0
13
1:256
7.17
14
1:256
7.0
15
1:256
7.17
16
1:256
7.0
17
1:512
7.17
18
1:512
7.33
19
1:512
7.5
20
1:512
7.67
21
1:1024
7.67
22
1:1024
7.83
Table 3 One-step growth dynamics of HAVH2K7P22 on KMB17 cells
Post inoculation days
Antigen titers
Infectious titers (LgCCID50/mL)
2
1:8
ND*
4
1:16
6.0
6
1:32
6.67
8
1:128
7.17
10
1:512
7.5
12
1:1024
7.8
14
1:1024
7.17
16
1:1024
7.0
18
1:1024
7.0
20
1:1024
6.83
22
1:1024
7.0
24
1:1024
6.8
26
1:2048
6.5
Table 4 Differences in the genome sequence and amino acids of the HAV H2 K7 with HAV H2K7 P6, HAV H2K7 P12, HAV H2K7 P18 and HAV H2 K7 P22
Nucleotide position
Location
Nucleotide
Amino acids
K7
K7P6
K7P12
K7P18
K7P22
K7
K7P6
K7P12
K7P18
K7P22
33
5'NTR
C
C
C
U
U
263
5'NTR
U
U
U
U
C
378
5'NTR
U
U
U
U
C
591
5'NTR
A
A
G
G
G
646
5'NTR
A
A
A
U
U
858
VP2
G
U
U
U
U
A
S
S
S
S
1178
VP2
C
U
U
U
U
I
I
I
I
I
4022
2B
T
C
C
C
C
I
I
I
I
I
4558
2C
A
A
A
A
C
Q
Q
Q
Q
P
4802
2C
U
U
U
U
C
A
A
A
A
A
4949
2C
A
A
A
A
U
T
T
T
T
T
4968
2C
A
C
C
C
C
N
H
H
H
H
5193
3A
C
U
U
U
U
R
C
C
C
C
5217
3A
G
G
G
G
U
A
A
A
A
S
5336
3C
G
G
G
G
A
L
L
L
L
L
5715
3C
A
A
A
G
G
T
T
T
A
A
6427
3D
U
U
U
G
G
V
V
G
G
G
7256
3D
A
U
U
U
U
A
A
A
A
A
Table 5 Identitiy comparisons of nucleotide sequence of HAVH2K7 with HAVH2K7P6 and HAVH2K7P22
Genomic region
HAVH2K7P6 (%)
HAVH2K7P12 (%)
HAVH2K7P18 (%)
HAVH2K7P22 (%)
GENOME
99.93
99.9
99.87
99.76
5'NTR
100
99.86
99.59
99.32
VP4 ENCODING
100
100
100
100
VP2 ENCODING
99.71
99.71
99.71
99.71
VP3 ENCODING
100
100
100
100
VP1 ENCODING
100
100
100
100
2A ENCODING
100
100
100
100
2B ENCODING
99.74
99.74
99.74
99.74
2C ENCODING
99.9
99.9
99.9
99.6
3A ENCODING
99.42
99.42
99.42
98.84
3B ENCODING
100
100
100
98.53
3C ENCODING
100
100
99.85
99.85
3D ENCODING
99.94
99.86
99.86
99.86
3'UTR
100
100
100
100
Citation: Hu NZ, Hu YZ, Shi HJ, Liu GD, Qu S. Mutational characteristics in consecutive passage of rapidly replicating variants of hepatitis A virus strain H2 during cell culture adaptation. World J Gastroenterol 2002; 8(5): 872-878